A nurse is reviewing the phases of pharmacokinetics. Which of the following phases is the change of a drug into a less or more potent or more soluble form after it passes through the liver?

A nurse is monitoring a client who is receiving spironolactone (Aldactone). Which of the following findings should the nurse report to the provider?

The nurse is educating a client about taking a tetracycline along with an antacid. The nurse explains to the client not to take these two medications because the antacid can reduce the absorption of the tetracycline. When one drug reduces the effect of another, it is:

A nurse is reviewing the phases of pharmacokinetics. Which of the following phases is the change of a drug into a less or more potent or more soluble form after it passes through the liver?

A nurse is educating a client about a new prescription for morphine sulfate (Astramorph). Which of the following statement should the nurse include in the teaching about morphine?

A client is prescribed cimetidine 200 milligrams (mg) PO twice daily. It is available as an oral liquid of 100 mg per teaspoon. How many teaspoons should the nurse instruct the client to take per dose?

A nurse is providing an in-service on the complications of naloxone (Narcan), such as abstinence syndrome. Which of the following signs and symptoms should the nurse include in her in-service about abstinence syndrome?

A nurse is preparing to administer naloxone (Narcan). The nurse understands that this medication has a rapid first-pass inactivation. The nurse understands that naloxone (Narcan) be administered in all of the following routes EXCEPT for:

Read the scenario and select the correct answers to complete the sentence:

Postoperative Medication Teaching

The nurse is performing postoperative medication teaching to an older mate client after a minor procedure to remove a superficial cyst on his upper back. The client is curious about the movement of the medication through his body and asks the nurse the name of the concept in which the medication moves from the site of administration, across body membranes, and to the circulating funds/bloodstream

The client is curious about the movement of the medication through his body. The client asks the nurse the name of the concept in which the medication moves from the site of administration, across body membranes, and to the circulating fluids/bloodstream.
How should the nurse best respond to explain this pharmacokinetic concept? 

The nurse is providing an in-service on non-steroidal anti-inflammatory drugs (NSAIDs). Which of the following medications is a first-generation NSAID that inhibits both COX-1 and COX-2 enzymes?

Which of the following statements is true about medications that are AGONISTS?